The 2018 Farm Bill, enacted more than eight months ago, included a provision that was designed to legalize industrial hemp on a broad scale. However, there are many lingering uncertainties for companies that are moving quickly in the hemp and hemp-derived cannabidiol (CBD) markets.
The new law builds on the success of the U.S. Department of Agriculture's (USDA) industrial hemp pilot program that was authorized in the 2014 Farm Bill and predominantly restricted to research universities. The U.S. Food and Drug Administration (FDA) is acting urgently to create a regulatory structure for cannabis-derived products, including those derived from hemp. There is enough of a foundation for companies to aggressively pursue the CBD market if they adhere to existing and evolving regulations and also closely follow case law and enforcement actions by federal and state agencies.
Join Holland & Knight attorneys Taite McDonald and Michael Werner as they provide insights gleaned from conversations with Congress, the FDA and the office at USDA responsible for writing the forthcoming hemp regulations, which will serve as the initial regulations for the market.
We hope you will join us for this highly informative presentation.
Continuing Legal Education (CLE)
Holland & Knight is an approved CLE provider in several jurisdictions, including California, Georgia, Illinois, New York and Texas. All reasonable efforts to seek CLE credits for this program will be made. In certain instances, some programs may not be awarded CLE credits because of either content or jurisdictional restrictions. For New York attorneys, this program's format qualifies for CLE for transitional (newly admitted) and experienced attorneys.
Continuing Professional Education Credits (CPE)
Holland & Knight can provide certificates of attendance that may be used to obtain CPE credit for nonlegal professions such as the HR Certification Institute (HRCI) and the Society for Human Resource Management (SHRM). Attendees should follow their appropriate organization's self-application procedures.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.